Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension.
作者信息
Mehdirad Ali, Karabin Beverly, Gupta Fiona
机构信息
Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, Saint Louis University, St. Louis, MO, USA.
Syncope and Autonomic Disorders Center, University of Toledo, Toledo, OH, USA.
出版信息
Clin Auton Res. 2017 Jul;27(Suppl 1):25-27. doi: 10.1007/s10286-017-0433-7. Epub 2017 Jun 20.
Abstract
摘要
相似文献
1
Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension.在一名患有帕金森病、心房颤动和高血压的患者中使用屈昔多巴治疗神经源性直立性低血压
Clin Auton Res. 2017 Jul;27(Suppl 1):25-27. doi: 10.1007/s10286-017-0433-7. Epub 2017 Jun 20.
2
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension.滴定屈昔多巴以最大化帕金森病合并神经源性直立性低血压患者的症状获益。
Clin Auton Res. 2017 Jul;27(Suppl 1):15-16. doi: 10.1007/s10286-017-0430-x. Epub 2017 Jul 11.
3
Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.调整屈昔多巴治疗帕金森病患者神经源性直立性低血压
Clin Auton Res. 2017 Jul;27(Suppl 1):17-19. doi: 10.1007/s10286-017-0431-9. Epub 2017 Jun 19.
4
Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension.在一名患有非糖尿病性自主神经病变且因神经源性直立性低血压接受屈昔多巴治疗的患者中管理仰卧位高血压。
Clin Auton Res. 2017 Jul;27(Suppl 1):35-37. doi: 10.1007/s10286-017-0436-4. Epub 2017 Jun 16.
5
Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.在一名帕金森病患者中启动屈昔多巴治疗神经源性直立性低血压。
Clin Auton Res. 2017 Jul;27(Suppl 1):13-14. doi: 10.1007/s10286-017-0429-3. Epub 2017 Jun 19.
6
Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.在患有神经源性直立性低血压和帕金森病的患者中，将屈昔多巴添加到氟氢可的松或米多君中。
Clin Auton Res. 2017 Jul;27(Suppl 1):29-31. doi: 10.1007/s10286-017-0434-6. Epub 2017 Jul 3.
7
Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.多重用药：使用屈昔多巴治疗一名帕金森病合并2型糖尿病患者的神经源性直立性低血压。
Clin Auton Res. 2017 Jul;27(Suppl 1):33-34. doi: 10.1007/s10286-017-0435-5. Epub 2017 Jul 3.
8
Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease.帕金森病患者疑似神经源性直立性低血压的鉴别诊断。
Clin Auton Res. 2017 Jul;27(Suppl 1):5-7. doi: 10.1007/s10286-017-0427-5. Epub 2017 Jul 3.
9
Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension.多佐胺可减少直立性低血压帕金森病患者的姿势摆动。
Parkinsonism Relat Disord. 2022 Jun;99:62-64. doi: 10.1016/j.parkreldis.2022.05.002. Epub 2022 May 13.
10
Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B).屈昔多巴用于帕金森病症状性神经源性直立性低血压的短期治疗（nOH306B）
Mov Disord. 2015 Apr 15;30(5):646-54. doi: 10.1002/mds.26086. Epub 2014 Dec 9.
引用本文的文献
1
Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications.血栓形成在神经退行性疾病中的作用：神经血管并发症的复杂机制
Mol Neurobiol. 2025 Apr;62(4):4802-4836. doi: 10.1007/s12035-024-04589-4. Epub 2024 Nov 1.
2
Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.神经原性直立性低血压的临床试验：终点、陷阱和挑战的综合评价。
Semin Neurol. 2020 Oct;40(5):523-539. doi: 10.1055/s-0040-1713846. Epub 2020 Sep 9.
3
Orthostatic Hypotension in Parkinson Disease.帕金森病患者的直立性低血压。
Clin Geriatr Med. 2020 Feb;36(1):53-67. doi: 10.1016/j.cger.2019.09.002. Epub 2019 Sep 6.
4
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.遗传性转甲状腺素蛋白淀粉样变性的直立性低血压：流行病学、诊断和治疗。
Clin Auton Res. 2019 Sep;29(Suppl 1):33-44. doi: 10.1007/s10286-019-00623-x. Epub 2019 Aug 26.
5
Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.帕金森病和其他突触核蛋白病自主神经功能障碍的治疗。
Mov Disord. 2018 Mar;33(3):372-390. doi: 10.1002/mds.27344.
本文引用的文献
1
Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.多巴丝肼治疗神经源性直立性低血压的安全性和有效性的荟萃分析。
Clin Auton Res. 2016 Jun;26(3):171-80. doi: 10.1007/s10286-016-0349-7. Epub 2016 Mar 7.
2
Supine hypertension in Parkinson's disease and multiple system atrophy.帕金森病和多系统萎缩中的仰卧位高血压
Clin Auton Res. 2016 Apr;26(2):97-105. doi: 10.1007/s10286-015-0336-4. Epub 2016 Jan 22.
3
Clinical characteristics of supine hypertension in de novo Parkinson disease.新发帕金森病患者仰卧位高血压的临床特征。
Clin Auton Res. 2016 Feb;26(1):15-21. doi: 10.1007/s10286-015-0324-8. Epub 2015 Nov 27.
4
Droxidopa in neurogenic orthostatic hypotension.屈昔多巴治疗神经源性直立性低血压。
Expert Rev Cardiovasc Ther. 2015;13(8):875-91. doi: 10.1586/14779072.2015.1057504. Epub 2015 Jun 19.
5
Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.CHA2DS2-VASc 评分对房颤抗凝推荐的影响。
Am J Med. 2012 Jun;125(6):603.e1-6. doi: 10.1016/j.amjmed.2011.09.030. Epub 2012 Apr 11.
Zotero 插件